Piramal Pharma announces Q1 FY27 results
July 30, 2026 | 12:01
Piramal Pharma, listed on both NSE and BSE, announced its standalone and consolidated results for the first quarter ended 30 June 2026, covering its global pharmaceutical and wellness business.
Mobile Version